Congratulations to Dr. Michel Sadelain for receiving the 2024 Breakthrough Prize Foundation’s Prize in Life Sciences for the development of chimeric antigen receptor T cell immunotherapy. – Memorial Sloan Kettering Cancer Center

Quoting Memorial Sloan Kettering Cancer Center on LinkedIn:

“Congratulations to Dr. Michel Sadelain, Director of the Center for Cell Engineering and the Gene Transfer and Gene Expression Laboratory at Memorial Sloan Kettering Cancer Center (MSK), for receiving the 2024 Breakthrough Prize Foundation‘s Prize in Life Sciences for the development of chimeric antigen receptor T cell immunotherapy.”

For details, click here.
Source: Memorial Sloan Kettering Cancer Center/LinkedIn